Caprolactam Chemicals Complete Financial Statements
In FY2026, Caprolactam Chemicals (CAPRO) reported revenue ₹11 Cr, net profit ₹2 Cr and EPS ₹3.83, with a net profit margin of 18.2% and ROE of 40.0%. Full financial statements from FY2015 to FY2026 (12 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. For live price, earnings ratios and company overview, see Caprolactam Chemicals stock price NSE.
Complete Financial Data Export
Profitability Ratios
Balance Sheet Ratios
CAPRO Revenue, Net Profit & EBITDA — Year-on-Year Growth
CAPRO YoY (March 2025 vs March 2026) — revenue +57.1%, net profit +300.0%, EBITDA +100.0%, expenses +20.0%. Also explore Caprolactam Chemicals stock price data download to track price trends across different timeframes.
CAPRO Income Statement — Revenue, EBITDA & Net Profit
Caprolactam Chemicals revenue ₹11 Cr, EBITDA ₹4 Cr, net profit ₹2 Cr, EPS ₹3.83 (2026) — net profit margin 18.2%. Analyse CAPRO promoter holding to track promoter, FII and institutional holdings.
| Particulars | March 2026 | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 11 | 7 | 7 | 10 | 3 | 6 | 7 | 5 | 4 | 3 | 5 | 3 |
| Expenses | 6 | 5 | 5 | 5 | 3 | 4 | 4 | 3 | 3 | 3 | 4 | 3 |
| EBITDA | 4 | 2 | 2 | 5 | 0 | 2 | 3 | 2 | 1 | 1 | 1 | 0 |
| Operating Profit Margin % | 42.00% | 23.00% | 31.00% | 48.00% | -27.00% | 34.00% | 39.00% | 36.00% | 22.00% | 14.00% | 17.00% | 13.00% |
| Depreciation | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 |
| Interest | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 2 | -1 | 0 | 3 | -2 | 1 | 1 | 1 | 0 | 0 | 1 | 0 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 2 | -1 | 0 | 3 | -1 | 1 | 1 | 1 | 0 | 0 | 1 | 0 |
| Earnings Per Share (₹) | 3.83 | -1.54 | 0.43 | 5.54 | -2.79 | 1.41 | 2.07 | 1.09 | 0.37 | -0.25 | 1.13 | -0.12 |
CAPRO Balance Sheet — Assets, Liabilities & Shareholders' Equity
CAPRO total assets ₹14 Cr, total equity ₹5 Cr, total liabilities ₹ Cr (2025) — ROE 40.0%.
| Particulars | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| Total Assets | 14 | 12 | 12 | 10 | 7 | 7 | 7 | 6 | 4 | 4 | 3 |
| Current Assets | 4 | 1 | 1 | 1 | 2 | 1 | 1 | 2 | 1 | 1 | 0 |
| Fixed Assets | 10 | 10 | 10 | 5 | 6 | 6 | 6 | 4 | 3 | 3 | 3 |
| Capital Work in Progress | 0 | 0 | 0 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 4 | 1 | 1 | 1 | 2 | 1 | 1 | 3 | 1 | 1 | 1 |
| LIABILITIES | |||||||||||
| Total Liabilities | |||||||||||
| Current Liabilities | 0 | 0 | 3 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-Current Liabilities | |||||||||||
| SHAREHOLDERS' EQUITY | |||||||||||
| Total Equity | 5 | 6 | 5 | 3 | 4 | 4 | 3 | 2 | 2 | 2 | 2 |
| Share Capital | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| Reserves & Surplus | 0 | 1 | 1 | -2 | -1 | -1 | -2 | -3 | -3 | -3 | -3 |
CAPRO Cash Flow Statement — Operating, Investing & Financing
Caprolactam Chemicals operating cash flow ₹-1 Cr, investing ₹-2 Cr, financing ₹2 Cr, net cash flow ₹0 Cr (2025).
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | -1 | 2 | 1 | 3 | 1 | 2 | 3 | 1 | 1 | 1 | 1 |
| Investing Activities | -2 | -2 | -2 | -5 | -1 | -1 | -4 | -1 | -1 | -1 | -2 |
| Financing Activities | 2 | 0 | 1 | 1 | -1 | -1 | 0 | 0 | 0 | 0 | 1 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 | 0 | -1 | 1 | 0 | 0 | 0 |